Company Filing History:
Years Active: 2006
Title: Dicky G Abraham: Innovator in Hepatitis B Vaccine Development
Introduction
Dicky G Abraham is a notable inventor based in North Wales, PA, who has made significant contributions to the field of vaccine development. He is recognized for his innovative work in improving the hepatitis B surface antigen, which plays a crucial role in vaccine efficacy.
Latest Patents
Abraham holds a patent for the recombinant hepatitis B surface antigen (rHBsAg). This invention provides an improved rHBsAg that exhibits higher antigenicity and immunogenicity than previously known variants. The method of producing this enhanced rHBsAg allows for the creation of vaccines that require lower amounts of active ingredients while achieving higher immunogenicity. Additionally, these vaccines can be combined to offer protective immunization against hepatitis B virus and other infectious agents.
Career Highlights
Dicky G Abraham is affiliated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has been pivotal in advancing vaccine technology and improving public health outcomes.
Collaborations
Abraham has collaborated with esteemed colleagues such as Qinjian Zhao and Robert D Sitrin, contributing to the collective expertise in vaccine research and development.
Conclusion
Dicky G Abraham's innovative contributions to hepatitis B vaccine development highlight his importance in the field of immunology. His work continues to impact vaccine efficacy and public health positively.